logo

Drop us a Line

Lorem ipsum dolor sit amet,
consectetuer ux adipis cing elit, sed

NAME@YOURSITE.COM

Developing better drugs

We develop new drug formulations for the treatment of a variety of pulmonary conditions.

KUSUDAMA Therapeutics SL is a technology-based spin-off from CIDETEC, one of the most important private technology centres in the Basque Country. The company’s objective is to develop new drug formulations for the treatment of a variety of pulmonary conditions.

OUR PROJECT

KUSUDAMA technology

Our technology is based on the nanomedicine platform known as KuDa, developed by CIDETEC. The technology is patented in the European Union and in the United States. The nanomedicine platform is based on a new methodology for manufacturing single chain nanoparticles (SCNP) in an aqueous medium at room temperature and in the absence of catalysts, by cross-linking the polymer chain with a bifunctional agent.

The platform is designed to develop new products in the area of respiratory diseases. Due to its physical-chemical properties and size (15-40 nanometres), it will be able to remain in the lungs for longer periods of time and achieve greater penetration of the pulmonary mucus.

It is a versatile platform that allows various active ingredients to be included by means of electrostatic or covalent interactions. The particles are suitable for administration by nebulisation.

MAIN ADVANTAGES

The KuDa platform

KuDa directs the active ingredient, increasing its efficacy.

  • Improved stability of the active Ingredients
  • High loading capacity of active ingredients (up to 40% by weight)
  • Reduction in toxicity of the active ingredients in vitro and in vivo
  • Good distribution in the lungs
  • Modulation of the release of the active ingredients
  • Improved efficacy of active ingredients in vivo
  • Allows the final product to be lyophilised or kept in solution/dispersion

KUSUDAMA

Developer Team

The company is headed by a first-rate team with experience in drug development, venture capital and licensing, which will ensure an efficient management focused on product development.

team00

Fermín Goytisolo

Chief Executive Officer (CEO)

fgoytisolo@kusudama.eu

team01

Xabier Murgia

Chief Scientific Officer (CSO)

xmurgia@kusudama.eu

A first-rate team

The company is headed by a first-rate team with experience in drug development, venture capital and licensing, which will ensure an efficient management focused on product development.

CONTACT

Let’s talk

logo-footer

Parque Científico y Tecnológico de Gipuzkoa

Pº Miramón, 196
20014 Donostia – San Sebastián

    I accept the terms & conditions and the privacy policy.

    I accept to receive advertising from Kusudama.

    Esta web utiliza cookies propias y de terceros para su correcto funcionamiento y para fines analíticos. Al hacer clic en el botón Aceptar, acepta el uso de estas tecnologías y el procesamiento de tus datos para estos propósitos. Ver
    Privacidad